반려동물 리스크 평가 시장 예측(-2034년) : 솔루션 유형별, 동물 유형별, 리스크 유형별, 기술, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Companion Animal Risk Assessment Market is accounted for $0.6 billion in 2026 and is expected to reach $2.1 billion by 2034 growing at a CAGR of 16.9% during the forecast period. Companion Animal Risk Assessment refers to the systematic evaluation of potential health, behavioral, environmental, nutritional, and disease-related risks affecting companion animals through structured assessment methodologies and data-driven analysis. It involves identifying, measuring, and prioritizing risk factors to support preventive care, clinical decision-making, and long-term health management. By integrating veterinary information, diagnostic findings, and environmental indicators, companion animal risk assessment enables early risk identification, improves care planning, enhances animal welfare, and supports informed veterinary interventions.

Market Dynamics:

Driver:

Preventive care emphasis

The global shift toward preventive veterinary care is driving substantial demand for companion animal risk assessment solutions that identify potential health issues before clinical symptoms develop. Veterinary professionals increasingly recognize that early risk identification enables interventions that improve outcomes and reduce treatment costs. Pet insurance providers leverage risk assessment data to develop personalized wellness plans and accurate premium pricing. End-user pet owners educated about preventive care benefits actively seek genetic testing and health screening services. The integration of risk scores into routine wellness examinations normalizes predictive health management.

Restraint:

Data privacy concerns

The collection and analysis of genetic and health data for companion animals raises significant privacy concerns that threaten market growth. Pet owners worry that genetic information revealing predispositions to hereditary diseases could affect insurance coverage or breeding decisions. Data breaches involving sensitive animal health information compromise consumer trust in risk assessment platforms. Regulatory frameworks for animal genetic data protection remain underdeveloped compared to human health data standards. These privacy challenges necessitate robust data security measures and transparent consent processes.

Opportunity:

Insurance integration

The convergence of risk assessment technology with pet insurance products presents transformative market expansion opportunities. Risk-based insurance pricing models use assessment data to offer personalized premiums reflecting individual animal health profiles. Preventive care incentives tied to risk assessment completion encourage pet owner engagement with wellness programs. Claims prediction models help insurers identify high-risk policyholders for proactive intervention. Partnerships between risk assessment platform providers and insurance companies create integrated health management ecosystems that benefit animals, owners, and insurers.

Threat:

False positive anxiety

The potential for risk assessment algorithms to generate false positive predictions creates anxiety among pet owners and veterinarians that threatens market acceptance. Overprediction of disease risk leads to unnecessary diagnostic testing, therapeutic interventions, and owner distress. Incomplete genetic databases for diverse breeds and mixed-breed animals reduce prediction accuracy. The psychological burden of knowing genetic predispositions without available preventive measures challenges the value proposition. These concerns necessitate careful communication of risk probabilities and uncertainty ranges.

Covid-19 Impact:

The COVID-19 pandemic accelerated companion animal risk assessment adoption as increased pet ownership created demand for preventive health information. Lockdown periods drove online genetic testing purchases and digital health platform registrations. However, veterinary clinic restrictions temporarily limited professional interpretation and follow-up services. Post-pandemic, the enlarged pet population and heightened health awareness support continued investment in risk assessment infrastructure.

The health risk assessment platforms segment is expected to be the largest during the forecast period

The health risk assessment platforms segment is expected to account for the largest market share during the forecast period, due to its comprehensive analysis of clinical, lifestyle, and environmental factors affecting companion animal health. Health risk platforms aggregate data from veterinary records, wearable devices, nutrition logs, and activity monitors to generate holistic risk profiles. The systems identify modifiable risk factors, including obesity, dental disease, and parasitic exposure, that respond to preventive interventions. Growing integration with practice management software enables seamless risk assessment during routine wellness visits. Major veterinary diagnostic companies embed health risk modules into comprehensive wellness screening panels.

The dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dogs segment is predicted to witness the highest growth rate, driven by increasing pet ownership, rising expenditure on preventive veterinary care, and growing awareness of early disease detection. Greater adoption of AI-enabled health monitoring, genetic screening, and personalized risk assessment tools is accelerating market expansion. Additionally, the high prevalence of chronic conditions and age-related disorders in dogs is boosting demand for continuous risk evaluation, positioning the dogs segment as the fastest-growing category in the Companion Animal Risk Assessment Market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high pet insurance penetration and advanced veterinary diagnostic infrastructure supporting risk assessment adoption. The United States leads with extensive direct-to-consumer genetic testing markets and sophisticated veterinary specialty services. Canada contributes through its progressive animal health research and well-funded veterinary institutions. High disposable incomes and cultural emphasis on preventive healthcare drive consumer demand for risk assessment services. Major companies, including Zoetis, IDEXX Laboratories, and Mars Science & Diagnostics, maintain significant market presence across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding pet ownership and increasing awareness of advanced veterinary care options. China and Japan represent major growth markets with growing middle-class pet ownership and the modernization of veterinary diagnostic capabilities. South Korea and Australia demonstrate high technology adoption rates and interest in precision pet health. Growing pet insurance markets create demand for risk-based underwriting tools. The region's expanding biotechnology sector supports indigenous genomic research and the development of risk models.

Key players in the market

Some of the key players in Companion Animal Risk Assessment Market include Zoetis Inc., IDEXX Laboratories, Inc., Antech Diagnostics, Mars Science & Diagnostics, Basepaws, Wisdom Panel, Embark Veterinary, Inc., Neogen Corporation, Merck Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Virbac S.A., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, Pethealth Inc. and Trupanion, Inc..

Key Developments:

In June 2026, Elanco Animal Health Incorporated launched an artificial intelligence-powered genetic risk assessment platform analyzing over two hundred disease markers across canine and feline breeds for personalized preventive care recommendations.

In May 2026, Neogen Corporation secured a major contract deploying health risk assessment platforms across European pet insurance networks for dynamic premium pricing and preventive care incentive programs.

In April 2026, Pethealth Inc. introduced a next-generation wearable sensor integration platform combining activity monitoring with behavioral pattern analysis for early detection of health deterioration in companion animals.

In March 2026, Boehringer Ingelheim Animal Health expanded its disease prediction software to include environmental risk factor modeling, enabling location-based recommendations for parasite prevention and vaccination schedules.

Solution Types Covered:

• Health Risk Assessment Platforms
• Genetic Risk Assessment Solutions
• Disease Prediction Software
• Behavioral Risk Assessment Systems
• Insurance Risk Analytics
• Preventive Care Assessment Platforms
• AI-Based Risk Intelligence Solutions

Animal Types Covered:

• Dogs
• Cats
• Birds
• Small Mammals
• Reptiles
• Others

Risk Types Covered:

• Chronic Disease Risk
• Genetic Disorder Risk
• Obesity Risk
• Infectious Disease Risk
• Behavioral Risk
• Environmental Risk

Technologies Covered:

• Artificial Intelligence
• Machine Learning
• Genomic Analytics
• Big Data Analytics
• Cloud Computing
• Wearable Sensor Technology

End Users Covered:

• Veterinary Hospitals
• Veterinary Clinics
• Pet Insurance Providers
• Animal Diagnostic Laboratories
• Research Institutes
• Pet Owners

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Companion Animal Risk Assessment Market, By Solution Type

• 5.1 Health Risk Assessment Platforms
• 5.2 Genetic Risk Assessment Solutions
• 5.3 Disease Prediction Software
• 5.4 Behavioral Risk Assessment Systems
• 5.5 Insurance Risk Analytics
• 5.6 Preventive Care Assessment Platforms
• 5.7 AI-Based Risk Intelligence Solutions

6 Global Companion Animal Risk Assessment Market, By Animal Type

• 6.1 Dogs
• 6.2 Cats
• 6.3 Birds
• 6.4 Small Mammals
• 6.5 Reptiles
• 6.6 Others

7 Global Companion Animal Risk Assessment Market, By Risk Type

• 7.1 Chronic Disease Risk
• 7.2 Genetic Disorder Risk
• 7.3 Obesity Risk
• 7.4 Infectious Disease Risk
• 7.5 Behavioral Risk
• 7.6 Environmental Risk

8 Global Companion Animal Risk Assessment Market, By Technology

• 8.1 Artificial Intelligence
• 8.2 Machine Learning
• 8.3 Genomic Analytics
• 8.4 Big Data Analytics
• 8.5 Cloud Computing
• 8.6 Wearable Sensor Technology

9 Global Companion Animal Risk Assessment Market, By End User

• 9.1 Veterinary Hospitals
• 9.2 Veterinary Clinics
• 9.3 Pet Insurance Providers
• 9.4 Animal Diagnostic Laboratories
• 9.5 Research Institutes
• 9.6 Pet Owners

10 Global Companion Animal Risk Assessment Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Zoetis Inc.
• 13.2 IDEXX Laboratories, Inc.
• 13.3 Antech Diagnostics
• 13.4 Mars Science & Diagnostics
• 13.5 Basepaws
• 13.6 Wisdom Panel
• 13.7 Embark Veterinary, Inc.
• 13.8 Neogen Corporation
• 13.9 Merck Animal Health
• 13.10 Boehringer Ingelheim Animal Health
• 13.11 Ceva Sante Animale
• 13.12 Virbac S.A.
• 13.13 Dechra Pharmaceuticals PLC
• 13.14 Elanco Animal Health Incorporated
• 13.15 Heska Corporation
• 13.16 Pethealth Inc.
• 13.17 Trupanion, Inc.